JA
Joseph A. Yanchik Iii
Venture Partner at Apple Tree Partners
Cambridge, Massachusetts
Overview
Joseph A. Yanchik III is currently a Venture Partner at Apple Tree Partners in Cambridge, Massachusetts, specializing in biotechnology, mergers, and start-ups. With a background that includes roles as Co-Founder, CEO, and Director at Aileron Therapeutics and Co-Founder & CEO at Tokai Pharmaceuticals, Yanchik has a strong track record in strategic planning, drug development, and commercialization within the pharmaceutical industry.
Work Experience
Venture Partner
2020 - Current
Apple Tree Partners is a venture capital firm that invests in pharmaceuticals, biotech, medtech, and healthcare services.
Raised $5,000,000.00.
Owner
2019 - 2020
Co-Founder, CEO & Director
2005 - 2018
Board of Directors
2005 - 2017
Co-Founder & CEO
2005 - 2008
Tokai Pharmaceuticals specializes in developing and delivering therapies for patients living with cancer.
Venture Partner
2005 - 2009
Apple Tree Partners is a venture capital firm that invests in pharmaceuticals, biotech, medtech, and healthcare services.
Raised $5,000,000.00.
Vice President, Corporate Development and Legal Affairs
2004 - 2005
Mendel Biotechnology is a plant biotechnology company that develops genetic and chemical solutions for a range of agricultural markets.
Raised $20,234,078.00 from CFO Rick, Inc., Capricorn Partners, Monsanto and Ziff Brothers Investments.
Chief Financial Officer
2002 - 2004
Attorney
1997 - 1999
Attorney
1993 - 1997
Education
JD
1990 - 1993